Evan Wells, Ph.D.

Chemical Engineering Ph.D. looking for opportunities in biopharma

About Me

My name is Evan Wells and I am a PhD chemical engineer with expertise in mammalian cell culture, protein production, and protein characterization.

I am most skilled in: antibody production, antibody glycosylation and maximizing cell culture efficiency.

Experience

Carnegie Mellon University

Graduate Researcher

August 2015 - December 2020

cmu.edu

Advisor: Prof. Anne Robinson,
Dissertation: Post-translational modifications to recombinant proteins: Roles in antibody production and neurodegenerative disease

Determined the effects of media supplementation and process conditions on antibody production and antibody glycosylation in shake flask and bench-scale bioreactor CHO cell cultures.
Developed a platform for expressing and purifying phosphorylated tau from E. coli cultures. Characterized the effects of phosphorylation on tau protein isoelectric point and aggregation propensity.

Brody School of Medicine

Research Specialist

March 2014-June 2015

ecu.edu

Advisor: Prof. Tonya Zeczycki

Expressed, purified, and kinetically characterized transglutaminase 2, a protein involved in neurodegenerative diseases.

Education

Carnegie Mellon University

Ph.D. Chemical Engineering

2015-2020

Pittsburgh, PA

In addition to my graduate work, I served in various department level and university wide leadership positions

East Carolina University

B.S. Biochemistry, B.A. Chemistry

2009-2013

Greenville, NC

Outstanding senior award in Biochemistry

Publications

Media supplementation for targeted manipulation of monoclonal antibody galactosylation and fucosylation

https://onlinelibrary.wiley.com/doi/abs/10.1002/bit.27496

Evan Wells, Liqing Song, Madison Greer, Yu Luo, Varghese Kurian, Babatunde Ogunnaike, Anne S Robinson

We supplemented antibody-producing Chinese Hamster Ovary (CHO) cells with 2FP, galactose, and uridine and saw targeted effects on antibody glycosylation (e.g. galactosylation and fucosylation) without sacrificing culture growth or antibody yield.

Strategies to enhance productivity and modify product quality in therapeutic proteins

https://www.sciencedirect.com/science/article/abs/pii/S2211339818300443

Devesh Radhakrishnan, Evan A Wells, Anne Skaja Robinson

A review focused on practical ways to improve protein production in CHO bioprocesses.

Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement

https://onlinelibrary.wiley.com/doi/abs/10.1002/biot.201600105

Evan Wells, Anne Skaja Robinson

A review highlighting different model organisms to produce recombinant proteins for therapeutic usage.

15 (V/K) kinetic isotope effect and steady-state kinetic analysis for the transglutaminase 2 catalyzed deamidation and transamidation reactions

https://www.sciencedirect.com/science/article/abs/pii/S0003986118300547

Evan A Wells, Mark A Anderson, Tonya N Zeczycki

We determined the effects of increasing concentrations of putrescine on the kinetic mechanism of transglutaminase 2.

Personal Background

I was born and raised in North Carolina. After undergrad, I moved to New Orleans to start graduate school at Tulane before following my advisor to Carnegie Mellon in Pittsburgh to finish my Ph.D. Aside from biotechnology, some of my other interests include:

  • Watching movies
  • Reading a mixture of science fiction, fantasy, and nonfiction books
  • Enjoying the outdoors
  • Cooking enjoyable meals